H.C. Wainwright Downgrades Galectin Therapeutics (GALT) to Neutral
Tweet Send to a Friend
(Updated - December 27, 2024 12:32 PM EST)
H.C. Wainwright analyst Ed Arce downgraded Galectin Therapeutics (NASDAQ: GALT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Ed Arce downgraded Galectin Therapeutics (NASDAQ: GALT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
